Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCN10A mRNA is the messenger RNA transcript that encodes the alpha subunit of the voltage-gated sodium channel Nav1.8 (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947615/; MedlinePlus, https://medlineplus.gov/genetics/gene/scn10a/). This channel is primarily localized in the nociceptive neurons of the dorsal root ganglia (DRG) and is essential for the initiation and propagation of action potentials in sensory neurons, making it a key mediator of peripheral pain processing (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501145/). In pathological states such as neuropathic or inflammatory pain, SCN10A expression is often upregulated, contributing to neuronal hyperexcitability and chronic pain (ResearchGate, https://www.researchgate.net/publication/380468434_SCN10A_A_drug_target_for_pain_and_cardiac_arrhythmia). Therapeutic strategies targeting SCN10A mRNA, such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), seek to silence the expression of Nav1.8, offering a highly selective alternative to traditional analgesics (Google Patents, https://patents.google.com/patent/WO2015044361A1/en). Additionally, SCN10A has been implicated in cardiac electrophysiology, with genome-wide association studies linking its variants to atrial fibrillation and Brugada syndrome (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151654/). Therefore, targeting SCN10A mRNA requires careful consideration of both its analgesic potential and its role in cardiac conduction (Oxford Academic, https://academic.oup.com/eurheartj/article/46/7/744/7914441).
Inhibition of translation and induction of mRNA degradation via RNase H-mediated cleavage (for ASOs) or the RNA-induced silencing complex (RISC) (for siRNAs), leading to reduced expression of the Nav1.8 sodium channel protein (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158451/; Google Patents, https://patents.google.com/patent/WO2015044361A1/en).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium channel protein type 10 subunit alpha mRNA (SCN10A mRNA).